Scott Garland

Scott Garland serves as CEO at Day One Biopharmaceuticals. Day One Biopharmaceuticals operates in the research sector with approximately 210.0 employees. The company is headquartered in South San Francisco, California. Day One Biopharmaceuticals generates annual revenue of 100000000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 3 executives at Day One Biopharmaceuticals.
• • 13,743 executive contacts are available in California.
• • Our database includes 201,469 c suite-level executives.

Salesforce Sendgrid Outlook Greenhouse.io WP Engine Adobe Marketing Cloud reCAPTCHA WordPress.org Google Font API Mobile Friendly Vimeo Google Analytics Google Tag Manager Typekit Gravity Forms Lever Remote AI

oncology cancer drug development biotechnology pediatric oncology targeted therapies mapk neurooncology glioma childhood cancer translational medicine hematology biotechnology: pharmaceutical preparations health care biotechnology research cancer therapies tovorafenib clinical trials pediatric cancer adult cancer biopharmaceuticals pipeline fda approval drug licensing antibody drug conjugate (adc) therapeutics patient advocacy community engagement patients investigator-sponsored research safety & efficacy accessible treatments life-threatening diseases breakthrough medicines childhood brain tumors children with cancer pharmaceutical industry medical research patient outcomes market development adverse event reporting inclusion & diversity corporate governance investor relations financial performance pharmaceutical compliance team collaboration regulatory affairs clinical development treatment options personalized medicine community support family engagement healthcare innovation patient resources clinical programs drug pipeline medical professionals health inequalities innovative treatments childhood cancers adult cancers precision medicine fda-approved products ojemda antibody-drug conjugate patient-centric approach rare diseases genetic disorders personalized therapies healthcare collaboration unmet medical needs compassionate care cancer biology therapeutic efficacy patient support programs partnerships pediatric low-grade glioma cancer research treatment outcomes hospital & health care health wellness & fitness

JS

John Stubenrauch Chief Technology Officer at Day One Biopharmaceuticals

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

Outreach Guidance — research Sector

Executives like Scott Garland in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Day One Biopharmaceuticals.

How do I reach Scott Garland directly?

Scott Garland's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Day One Biopharmaceuticals. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Scott Garland work for?

Scott Garland is CEO at Day One Biopharmaceuticals, a company in the research sector with 210.0 employees. The company is based in South San Francisco, California.

Can I pitch or sell to Scott Garland?

As CEO at Day One Biopharmaceuticals, Scott Garland is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Scott Garland directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Scott Garland in?

Scott Garland works in the research industry as CEO at Day One Biopharmaceuticals. MessageCEO provides verified contact information for executives across all major industries.

Is Scott Garland's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Scott Garland's profile is kept up-to-date with the latest available information.

Last updated: May 12, 2026